Sharemaestro company-news research for Doximity Inc (DOCS), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.

NYSE United States Measured evidence

Company news sentiment

DOCS news sentiment

Doximity Inc

Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.

Weighted tone65Neutral is 50
Constructive news tone 80/100 evidence confidence 100% direct company focus 14 current stories across 3 publishers
Latest weekly closeUSD 27.40week of 7 Aug 2026
Dominant catalystEarnings82/100 classification confidence
News data statusHealthy0 duplicate stories removed

Current company news

News confirmed by price

Constructive news tone is drawn from 14 fresh independent stories, including 14 company-specific items across 3 publishers.

Latest source headline 1 Cash-Producing Stock with Promising Prospects and 2 We Ignore finance.yahoo.com · 12 Aug 2026 04:37

What supports the read

Direct evidence

14 current stories are mapped specifically to DOCS.

Source breadth

The read spans 3 publishers rather than depending on one outlet.

Narrative agreement

Cross-story agreement is 81/100, indicating a comparatively coherent tape.

Price response

Constructive news tone is being confirmed by positive weekly price action.

What tempers the read

No material evidence constraint is currently dominant.

65/100
Weighted toneConstructive news tone
80/100
Evidence confidencehigh confidence
100%/100
Company focus14 direct stories
81/100
Evidence agreement19/100 dispersion

News history

Tone and story flow over 21 days

Daily weighted evidence
07 Aug: 4 stories08 Aug: 3 stories09 Aug: 1 stories10 Aug: 3 stories11 Aug: 2 stories12 Aug: 1 stories 07 Aug: tone 61, 4 stories08 Aug: tone 54, 3 stories09 Aug: tone 64, 1 stories10 Aug: tone 72, 3 stories11 Aug: tone 83, 2 stories12 Aug: tone 79, 1 stories 95505
24 Jul03 Aug13 Aug
Weighted toneStory volumeNeutral 50

Evidence confidence

What supports the score

Measured separately from tone

Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.

Sample depth100
11.92 effective stories
Source breadth60
3 independent publishers
Direct relevance100
company-specific evidence share
Freshness58
recency-weighted evidence
Agreement81
cross-story consistency
Source independence20
lower publisher concentration

Price context

Sentiment against the 26-week price path

News confirmed by price

Constructive news tone is being confirmed by positive weekly price action.

13 Feb 2026: close 25.02, indexed 100.020 Feb 2026: close 25.55, indexed 102.127 Feb 2026: close 24.53, indexed 98.006 Mar 2026: close 25.34, indexed 101.313 Mar 2026: close 24.37, indexed 97.420 Mar 2026: close 24.41, indexed 97.627 Mar 2026: close 23.69, indexed 94.703 Apr 2026: close 22.77, indexed 91.010 Apr 2026: close 21.05, indexed 84.117 Apr 2026: close 24.71, indexed 98.824 Apr 2026: close 24.01, indexed 96.001 May 2026: close 24.98, indexed 99.808 May 2026: close 25.98, indexed 103.815 May 2026: close 18.97, indexed 75.822 May 2026: close 19.94, indexed 79.729 May 2026: close 21.4, indexed 85.505 Jun 2026: close 20.59, indexed 82.312 Jun 2026: close 20.04, indexed 80.119 Jun 2026: close 20.46, indexed 81.826 Jun 2026: close 20.88, indexed 83.503 Jul 2026: close 21.86, indexed 87.410 Jul 2026: close 21.77, indexed 87.017 Jul 2026: close 21.52, indexed 86.024 Jul 2026: close 20.42, indexed 81.631 Jul 2026: close 20.91, indexed 83.607 Aug 2026: close 27.4, indexed 109.5 20 Jun 2026: sentiment 4420 Jun 2026: sentiment 4421 Jun 2026: sentiment 4422 Jun 2026: sentiment 4422 Jun 2026: sentiment 4422 Jun 2026: sentiment 4422 Jun 2026: sentiment 4422 Jun 2026: sentiment 4422 Jun 2026: sentiment 4423 Jun 2026: sentiment 4423 Jun 2026: sentiment 4423 Jun 2026: sentiment 4323 Jun 2026: sentiment 4323 Jun 2026: sentiment 4324 Jun 2026: sentiment 4324 Jun 2026: sentiment 4325 Jun 2026: sentiment 4425 Jun 2026: sentiment 4428 Jun 2026: sentiment 4328 Jun 2026: sentiment 4330 Jun 2026: sentiment 4630 Jun 2026: sentiment 4530 Jun 2026: sentiment 4430 Jun 2026: sentiment 4501 Jul 2026: sentiment 4501 Jul 2026: sentiment 4502 Jul 2026: sentiment 4402 Jul 2026: sentiment 4503 Jul 2026: sentiment 4503 Jul 2026: sentiment 4503 Jul 2026: sentiment 4505 Jul 2026: sentiment 4606 Jul 2026: sentiment 4707 Jul 2026: sentiment 4710 Jul 2026: sentiment 4711 Jul 2026: sentiment 4811 Jul 2026: sentiment 4715 Jul 2026: sentiment 4716 Jul 2026: sentiment 4819 Jul 2026: sentiment 4720 Jul 2026: sentiment 4720 Jul 2026: sentiment 4721 Jul 2026: sentiment 4722 Jul 2026: sentiment 4722 Jul 2026: sentiment 4729 Jul 2026: sentiment 5029 Jul 2026: sentiment 4929 Jul 2026: sentiment 4931 Jul 2026: sentiment 4902 Aug 2026: sentiment 4902 Aug 2026: sentiment 49
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
26-week price+9.5%latest close 27.4
Sentiment change+5available snapshot window
One-week response+31.0%Price confirming higher
Fair-value position-31.3%Below fair value
Sentiment-trend disagreementMarket Dynamics buy signalValue support

News subjects

What is shaping the score

Earnings
Earnings699 stories · 64%
Analyst action663 stories · 21%
Deals and strategy781 stories · 7%
Macro sensitivity611 stories · 7%

Source mix

Where the evidence comes from

20/100 independence
finance.yahoo.com6912 stories · 86%
cnbc.com781 stories · 7%
nasdaq.com411 stories · 7%

Recurring subjects

Subjects appearing most often

Current evidence
Earnings12AI8Price Target7Healthcare6Revenue Growth4Guidance4Ratings3Earnings Report2Earnings Per Share2Telehealth1

Earlier readings

How the score has changed

50 is the neutral baseline
ConstructiveBalanced or withheldCautious

Source headlines

The news behind the score

Showing 1-14 of 14

Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.

#179Tone
finance.yahoo.comDirect company coverage

1 Cash-Producing Stock with Promising Prospects and 2 We Ignore

1 Cash-Producing Stock with Promising Prospects and 2 We Ignore Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. Not all companies are created equal, and StockStory is here to surface the ones with real upside. That said, here is one cash-producing company that reinvests wisely to drive long-term success and two that may face some trouble. Two Stocks to Sell: Doximity (DOCS) Trailing 12-Month Free Cash Flow Margin: 45.3% With over 80% of U.S. ph

EarningsHealthcareIndustrialsPrice TargetRetailRevenue Growth
Published
12 Aug 2026 04:37
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated
#281Tone
finance.yahoo.comDirect company coverage

Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup

It's a great feeling when a stock you own absolutely skyrockets higher after reporting earnings. Two software-as-a-service (SaaS) stocks, Atlassian (NASDAQ: TEAM) and Doximity (NYSE: DOCS), gave their investors something to cheer about when both companies' share prices skyrocketed more than 30% this past Friday, Aug. 7, following their earnings reports. The two stocks had a few things in common going into the report. They both operate vertical-focused software platforms. In the case of Atlassian, its focus is on enterprise workflows, while Doximity's platform is centered on clinical workflows

Artificial IntelligenceEarningsEarnings ReportGuidanceRevenue GrowthSaas
Published
11 Aug 2026 17:49
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated
#385Tone
finance.yahoo.comDirect company coverage

DOCS Q2 Deep Dive: AI Product Adoption Fuels Revenue Growth, Margins Face Investment Pressures

DOCS Q2 Deep Dive: AI Product Adoption Fuels Revenue Growth, Margins Face Investment Pressures Medical professional network Doximity (NYSE:DOCS) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 7.3% year on year to $156.6 million. The company expects next quarter's revenue to be around $170.5 million, close to analysts' estimates. Its non-GAAP profit of $0.29 per share was 4.2% below analysts' consensus estimates. Is now the time to buy DOCS? Find out in our full research report (it's free). Doximity (DOCS) Q2 CY2026 Highlights: Revenue: $156.6 million vs analys

AIEarningsFree Cash FlowGuidanceHealthcareRatings
Published
11 Aug 2026 08:21
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated
#478Tone
cnbc.comDirect company coverage

Stocks making the biggest moves midday: NetApp, Intel, Apple, Doximity, Verisk Analytics & more

Check out some of the companies making the biggest moves midday: MarineMax — The boat and yacht retailer soared 46% after agreeing to be sold to Blackstone Infrastructure's Safe Harbor Marinas for $53 a share in cash, or $1.5 billion. The deal's expected to close by the end of 2026. Varex Imaging — The imaging component maker climbed 48% after Teledyne Technologies agreed to buy Varex for $18.90 a share in cash. The deal is expected to close in early 2027. Teledyne rose a fraction. Artificial intelligence infrastructure — Stocks tied to artificial intelligence infrastructure slid. The Global X

Abcellera BioloAbcellera Biologics IncApple IncArcher AviationArcher Aviation IncBerkshire Hatha
Published
10 Aug 2026 17:43
Catalyst
Deals and strategy
Evidence role
Direct company coverage
Duplicates
1 consolidated
#585Tone
finance.yahoo.comDirect company coverage

Apple downgraded, HPE upgraded: Wall Street's top analyst calls

Apple downgraded, HPE upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top Upgrades: Morgan Stanley upgraded HPE (HPE) to Overweight from Equal Weight with a price target of $69, down from $71. The firm admits to having been on the wrong side of the enterprise hardware trade, previously believing that record component inflation would quickly stymie a recovery in hardware spending, but its AlphaWise survey confirms this cyc

AIEarningsInfrastructurePrice TargetPrice TargetRatings
Published
10 Aug 2026 13:39
Catalyst
Analyst action
Evidence role
Direct company coverage
Duplicates
1 consolidated
#653Tone
finance.yahoo.comDirect company coverage

Doximity Draws Its First Downgrade Days After Its Pop

This article first appeared on GuruFocus. Doximity (NYSE:DOCS), a digital platform for U.S. medical professionals, was up 0.51% premarket despite a Wells Fargo downgrade to Underweight from Equal Weight and an $18 price target. The call lands days after the stock jumped 32.58% on its earnings report. Analyst Stan Berenshteyn said Doximity's outlook is essentially unchanged, but the stock now trades close to faster-growing peers after the run-up. At the current $27, it trades at about 32x earnings despite revenue growth of roughly 11% over the past year. He argued the remaining upside leans on

AIEarningsEarnings ReportPrice TargetPrice TargetRevenue Growth
Published
10 Aug 2026 12:20
Catalyst
Analyst action
Evidence role
Direct company coverage
Duplicates
1 consolidated
#764Tone
finance.yahoo.comDirect company coverage

Doximity (DOCS) Stock Fair Value Rises After Split Analyst Views On AI Growth

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Doximity's updated fair value estimate has moved from US$24.37 to US$28.00, which represents roughly a 15% uplift in the latest model. This shift lines up with the split analyst narrative, where some firms point to improving execution and AI traction, while others focus on execution risk, competition in healthcare AI, and the path for longer term growth. As you read on, you will see how to track these changing views and what to watch as the story around Doximity continues to

AIDigital MarketingEarningsHealthcarePrice TargetSplit
Published
09 Aug 2026 09:10
Catalyst
Analyst action
Evidence role
Direct company coverage
Duplicates
1 consolidated
#835Tone
finance.yahoo.comDirect company coverage

Doximity (DOCS) Is Up 31.0% After Raising Revenue Outlook On Clinical AI Adoption - Has The Bull Case Changed?

Doximity, Inc. recently reported fiscal first-quarter 2027 results, with revenue rising to US$156.62 million from US$145.91 million a year earlier, while net income and earnings per share declined year on year. Management emphasized rapid uptake and monetization of its clinical AI tools, updating guidance to US$170–171 million for second-quarter revenue and US$671–681 million for full-year revenue. We'll now examine how Doximity's raised revenue outlook, underpinned by accelerating adoption of its AI-powered products, shapes its broader investment narrative. The best AI stocks today may lie be

AIEarningsEarnings Per ShareGuidanceHealthcareNet Income
Published
08 Aug 2026 21:15
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated
#931Tone
finance.yahoo.comDirect company coverage

Why Doximity Stock Skyrocketed on Friday

Shares of Doximity (NYSE: DOCS) surged on Friday after management highlighted the remarkable returns it was beginning to realize on its artificial intelligence (AI) investments.Image source: Getty Images. Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue » Q1 results were just part of the story Doximity's revenue rose 7% year over year to $156.6 million in its fiscal 2027 firs

AIEarningsHealthcareRatingsTelehealth
Published
08 Aug 2026 17:26
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated
#1086Tone
finance.yahoo.comDirect company coverage

Doximity Q1 Earnings Call Highlights

Key Points Interested in Doximity, Inc.? Here are five stocks we like better. Strong Q1 performance: Doximity's fiscal 2027 first-quarter revenue rose 7% year over year to $157 million, while adjusted EBITDA reached $75 million, a 48% margin. The company raised its full-year revenue outlook to $671 million–$681 million. Clinical AI adoption accelerated: Workflow prescribers using Doximity's AI tools nearly doubled as a share of active users, AI prompt volume increased more than 25% sequentially, and AI Scribe usage rose tenfold year over year. Doximity said its Ask product had the lowest error

AIEarningsEarnings Per ShareGrowth RateHealthcareRevenue Growth
Published
08 Aug 2026 05:03
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated
#1141Tone
nasdaq.comDirect company coverage

Stocks Settle Higher as a Weak Jobs Report Allays Rate Hike Fears

The S&P 500 Index ($SPX) (SPY) closed up +0.62% on Friday, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.28%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +1.19%. September E-mini S&P futures (ESU26) rose +0.55%, and September E-mini Nasdaq futures (NQU26) rose +1.17%. Stock indices settled higher on Friday amid strength in corporate earnings results and reduced Fed rate hike fears. Stock indices found support on Friday as bond yields fell after US July nonfarm payrolls unexpectedly declined and average hourly earnings rose less than expected, bolstering speculation that the

CybersecurityEarningsEarnings ResultsInterest RatesOperating IncomePrice Target
Published
07 Aug 2026 22:18
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated
#1245Tone
finance.yahoo.comDirect company coverage

Why Doximity Stock Is Soaring 38% After an Earnings Miss

Shares surge, even after the medical networking and telehealth company’s earnings miss analysts’ targets. Continue Reading

Earnings
Published
07 Aug 2026 19:18
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated
#1380Tone
finance.yahoo.comDirect company coverage

Why Doximity Stock Is Up 80%

This article first appeared on GuruFocus. Doximity (NYSE:DOCS), a digital platform for U.S. medical professionals, rose 79.82% intraday, after comments about the margins on its new AI search tool. CEO Jeffrey Tangney told analysts the product earns more than 10 times per search in revenue than it costs to run. The quarter itself was solid but not enough to explain the move. Revenue rose 7% to $156.6 million and adjusted EBITDA was $74.8 million, both above consensus, and Doximity raised its full-year revenue guidance by $6 million to a range of $671 million to $681 million. Piper Sandler's Jes

AIEarningsGuidanceShort Squeeze
Published
07 Aug 2026 18:43
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated
#1461Tone
finance.yahoo.comDirect company coverage

SpaceX, Doximity, Trade Desk, Rigetti, Coherent, and More Stocks That Explain Today’s Market

FEATURE Stocks rose Friday with tech names picking up steam after the U.S. jobs report for July was softer than expected, resulting in Wall Street rethinking whether the Federal Reserve will raise interest rates any time soon. Continue Reading

FedJobs ReportRatesTech
Published
07 Aug 2026 18:03
Catalyst
Macro sensitivity
Evidence role
Direct company coverage
Duplicates
1 consolidated

Earlier company news

DOCS news archive

Archive building

Stored newest first for historical research. These older headlines are retained for reference and do not contribute to the current sentiment gauge above.

The archive is starting now

Each successful collection will retain its qualifying headlines here instead of replacing the previous set.

How the page works

How to read the score

Tone is directional

It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.

Confidence is separate

Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.

Price is confirmation

Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.

Classification, not prediction

The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.

Evidence context